Bioleaf
PrivateLast Round
Pre Seed
Apr 1, 2024
Company Overview
Bioleaf operates in Energy & Sustainability and is based in Israel. It was founded in 2018.
Bioleaf is an ag-tech company that develops natural, eco-friendly, post-harvest solutions to prolong the shelf life of fresh produce using a patented encapsulation technology.
Sector
Energy & Sustainability
Verticals
Biotechnology, Supply Chain
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioleaf Comparables
Compare Bioleaf with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AgroSustain | 85% | |
| Nabaco Inc. | 82% | |
| Ryp Labs | 82% |
For institutional investors. Book with your work email.
Bioleaf Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2024
$1M raised in Pre Seed round.
For institutional investors. Book with your work email.
Bioleaf Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bioleaf's valuation, stock price, and market status.
Is Bioleaf a public or private company?
Bioleaf is a private company.
What is the current stock price of Bioleaf?
Bioleaf is a private company, so its shares have no public market price. Caplight tracks Bioleaf's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bioleaf worth (valuation)?
Valuation information for Bioleaf is not publicly available.
Can I buy Bioleaf stock?
Bioleaf shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bioleaf's last funding round?
Bioleaf's most recent funding round was Pre Seed on April 1, 2024.
Who are the main investors in Bioleaf?
Investor information for Bioleaf is not publicly disclosed.
Will Bioleaf IPO soon?
No public IPO plans have been announced for Bioleaf.
How can I track Bioleaf secondary market activity?
Caplight tracks bids, offers, and trades in Bioleaf's shares on secondary markets.